Otsu, Japan

Kunihiko Kiyono

USPTO Granted Patents = 4 

Average Co-Inventor Count = 11.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1995-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Kunihiko Kiyono

Introduction

Kunihiko Kiyono is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceutical innovations, holding a total of four patents. His work focuses on developing compounds that have therapeutic applications, particularly in the area of collagen generation and activation inhibitors.

Latest Patents

One of his latest patents is a STAT3/5 activation inhibitor. The objective of this invention is to provide an effective inhibitor that contains an aromatic compound represented by a specific general formula. This compound is designed to target and inhibit the activation of STAT3 and STAT5, which are critical in various biological processes. Another significant patent involves aromatic compounds for suppressing the generation of collagen. This novel compound demonstrates an excellent effect in reducing collagen generation while maintaining a high safety profile.

Career Highlights

Kunihiko Kiyono is currently associated with Otsuka Pharmaceutical Company, Limited. His work at this esteemed organization has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

He has collaborated with notable coworkers such as Keisuke Miyajima and Satoshi Yamada. Their combined expertise has fostered a productive environment for innovation and research.

Conclusion

Kunihiko Kiyono's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to developing effective and safe therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…